Dizal Reveals Promising Hematology Pipeline Developments at ASH 2025 Dizal Pharmaceuticals showcased new advancements in its hematology pipeline, presenting promising data on golidocitinib and birelentinib during ASH 2025.

Dizal Reveals Promising Hematology Pipeline Developments at ASH 2025 #China #Shanghai #Dizal #Golidocitinib #SSE688192